revusiran

revusiran
Trade Name
Orphan Indication Hereditary ATTR amyloidosis
USA Market Approval USA
USA Designation Date 2015-05-18 00:00:00
Sponsor Alnylam Pharmaceuticals, Inc.;300 Third Street;Cambridge, Massachusetts, 02142